Autologous Matrix-Induced Chondrogenesis (AMIC) Market Report

China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 20, 2022
  • PAGES：169
  • REPORT CODE：GMM1038652
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Autologous Matrix-Induced Chondrogenesis (AMIC) market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Autologous Matrix-Induced Chondrogenesis (AMIC) market. Detailed analysis of key players, along with key growth strategies adopted by Autologous Matrix-Induced Chondrogenesis (AMIC) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Geistlich Pharma AG

    • BioTissue AG

    • JRI Orthopaedics Ltd

    • B Braun Melsungen AG

    • Smith and Nephew plc

    • Arthro-Kinetics

    • Matricel GmbH

    • CartiHeal

    • Anika Therapeutics, Inc

    • Zimmer Biomet Holdings

    By Type:

    • Hyaluronic Acid

    • Collagen

    • Polyethylene glycol (PEG)

    • polylactic-co-glycolic acid (PGLA)

    • Others

    By End-User:

    • Knee Cartilage Repair

    • Hip Cartilage Repair

    • Elbow Cartilage Repair

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Autologous Matrix-Induced Chondrogenesis (AMIC) Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Hyaluronic Acid from 2016 to 2027

    • 1.3.2 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Collagen from 2016 to 2027

    • 1.3.3 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Polyethylene glycol (PEG) from 2016 to 2027

    • 1.3.4 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of polylactic-co-glycolic acid (PGLA) from 2016 to 2027

    • 1.3.5 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Knee Cartilage Repair from 2016 to 2027

    • 1.4.2 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Hip Cartilage Repair from 2016 to 2027

    • 1.4.3 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Elbow Cartilage Repair from 2016 to 2027

    • 1.4.4 China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Autologous Matrix-Induced Chondrogenesis (AMIC) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Autologous Matrix-Induced Chondrogenesis (AMIC) by Major Types

    • 3.4.1 Market Size and Growth Rate of Hyaluronic Acid

    • 3.4.2 Market Size and Growth Rate of Collagen

    • 3.4.3 Market Size and Growth Rate of Polyethylene glycol (PEG)

    • 3.4.4 Market Size and Growth Rate of polylactic-co-glycolic acid (PGLA)

    • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Autologous Matrix-Induced Chondrogenesis (AMIC) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Autologous Matrix-Induced Chondrogenesis (AMIC) by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Autologous Matrix-Induced Chondrogenesis (AMIC) in Knee Cartilage Repair

    • 4.4.2 Market Size and Growth Rate of Autologous Matrix-Induced Chondrogenesis (AMIC) in Hip Cartilage Repair

    • 4.4.3 Market Size and Growth Rate of Autologous Matrix-Induced Chondrogenesis (AMIC) in Elbow Cartilage Repair

    • 4.4.4 Market Size and Growth Rate of Autologous Matrix-Induced Chondrogenesis (AMIC) in Others

    5 Market Analysis by Regions

    • 5.1 China Autologous Matrix-Induced Chondrogenesis (AMIC) Production Analysis by Regions

    • 5.2 China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis

    • 6.1 North China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major Types

    • 6.2 North China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major End-Users

    7 Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis

    • 7.1 Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major Types

    • 7.2 Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major End-Users

    8 South China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis

    • 8.1 South China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major Types

    • 8.2 South China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major End-Users

    9 East China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis

    • 9.1 East China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major Types

    • 9.2 East China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major End-Users

    10 Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis

    • 10.1 Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major Types

    • 10.2 Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major End-Users

    11 Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis

    • 11.1 Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major Types

    • 11.2 Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major End-Users

    12 Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis

    • 12.1 Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major Types

    • 12.2 Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Geistlich Pharma AG

      • 13.1.1 Geistlich Pharma AG Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 BioTissue AG

      • 13.2.1 BioTissue AG Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 JRI Orthopaedics Ltd

      • 13.3.1 JRI Orthopaedics Ltd Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 B Braun Melsungen AG

      • 13.4.1 B Braun Melsungen AG Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Smith and Nephew plc

      • 13.5.1 Smith and Nephew plc Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Arthro-Kinetics

      • 13.6.1 Arthro-Kinetics Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Matricel GmbH

      • 13.7.1 Matricel GmbH Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 CartiHeal

      • 13.8.1 CartiHeal Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Anika Therapeutics, Inc

      • 13.9.1 Anika Therapeutics, Inc Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Zimmer Biomet Holdings

      • 13.10.1 Zimmer Biomet Holdings Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Hyaluronic Acid from 2016 to 2027

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Collagen from 2016 to 2027

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Polyethylene glycol (PEG) from 2016 to 2027

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of polylactic-co-glycolic acid (PGLA) from 2016 to 2027

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Knee Cartilage Repair from 2016 to 2027

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Hip Cartilage Repair from 2016 to 2027

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Elbow Cartilage Repair from 2016 to 2027

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Autologous Matrix-Induced Chondrogenesis (AMIC) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Autologous Matrix-Induced Chondrogenesis (AMIC)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Autologous Matrix-Induced Chondrogenesis (AMIC) by Different Types from 2016 to 2027

    • Table Consumption Share of Autologous Matrix-Induced Chondrogenesis (AMIC) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Hyaluronic Acid

    • Figure Market Size and Growth Rate of Collagen

    • Figure Market Size and Growth Rate of Polyethylene glycol (PEG)

    • Figure Market Size and Growth Rate of polylactic-co-glycolic acid (PGLA)

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Autologous Matrix-Induced Chondrogenesis (AMIC) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Autologous Matrix-Induced Chondrogenesis (AMIC) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Knee Cartilage Repair

    • Figure Market Size and Growth Rate of Hip Cartilage Repair

    • Figure Market Size and Growth Rate of Elbow Cartilage Repair

    • Figure Market Size and Growth Rate of Others

    • Table China Autologous Matrix-Induced Chondrogenesis (AMIC) Production by Regions

    • Table China Autologous Matrix-Induced Chondrogenesis (AMIC) Production Share by Regions

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Production Share by Regions in 2016

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Production Share by Regions in 2021

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Production Share by Regions in 2027

    • Table China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Regions

    • Table China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Regions

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Regions in 2016

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Regions in 2021

    • Figure China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Regions in 2027

    • Table North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Types from 2016 to 2027

    • Table North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types from 2016 to 2027

    • Figure North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2016

    • Figure North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2021

    • Figure North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2027

    • Table North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by End-Users from 2016 to 2027

    • Table North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users from 2016 to 2027

    • Figure North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2016

    • Figure North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2021

    • Figure North China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2027

    • Table Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Types from 2016 to 2027

    • Table Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types from 2016 to 2027

    • Figure Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2016

    • Figure Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2021

    • Figure Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2027

    • Table Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by End-Users from 2016 to 2027

    • Table Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2016

    • Figure Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2021

    • Figure Central China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2027

    • Table South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Types from 2016 to 2027

    • Table South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types from 2016 to 2027

    • Figure South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2016

    • Figure South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2021

    • Figure South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2027

    • Table South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by End-Users from 2016 to 2027

    • Table South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users from 2016 to 2027

    • Figure South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2016

    • Figure South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2021

    • Figure South China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2027

    • Table East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Types from 2016 to 2027

    • Table East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types from 2016 to 2027

    • Figure East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2016

    • Figure East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2021

    • Figure East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2027

    • Table East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by End-Users from 2016 to 2027

    • Table East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users from 2016 to 2027

    • Figure East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2016

    • Figure East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2021

    • Figure East China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2027

    • Table Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Types from 2016 to 2027

    • Table Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2016

    • Figure Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2021

    • Figure Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2027

    • Table Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by End-Users from 2016 to 2027

    • Table Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2016

    • Figure Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2021

    • Figure Northeast China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2027

    • Table Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Types from 2016 to 2027

    • Table Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2016

    • Figure Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2021

    • Figure Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2027

    • Table Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by End-Users from 2016 to 2027

    • Table Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2016

    • Figure Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2021

    • Figure Southwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2027

    • Table Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by Types from 2016 to 2027

    • Table Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2016

    • Figure Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2021

    • Figure Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by Types in 2027

    • Table Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption by End-Users from 2016 to 2027

    • Table Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2016

    • Figure Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2021

    • Figure Northwest China Autologous Matrix-Induced Chondrogenesis (AMIC) Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Geistlich Pharma AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Geistlich Pharma AG

    • Figure Sales and Growth Rate Analysis of Geistlich Pharma AG

    • Figure Revenue and Market Share Analysis of Geistlich Pharma AG

    • Table Product and Service Introduction of Geistlich Pharma AG

    • Table Company Profile and Development Status of BioTissue AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioTissue AG

    • Figure Sales and Growth Rate Analysis of BioTissue AG

    • Figure Revenue and Market Share Analysis of BioTissue AG

    • Table Product and Service Introduction of BioTissue AG

    • Table Company Profile and Development Status of JRI Orthopaedics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of JRI Orthopaedics Ltd

    • Figure Sales and Growth Rate Analysis of JRI Orthopaedics Ltd

    • Figure Revenue and Market Share Analysis of JRI Orthopaedics Ltd

    • Table Product and Service Introduction of JRI Orthopaedics Ltd

    • Table Company Profile and Development Status of B Braun Melsungen AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of B Braun Melsungen AG

    • Figure Sales and Growth Rate Analysis of B Braun Melsungen AG

    • Figure Revenue and Market Share Analysis of B Braun Melsungen AG

    • Table Product and Service Introduction of B Braun Melsungen AG

    • Table Company Profile and Development Status of Smith and Nephew plc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Smith and Nephew plc

    • Figure Sales and Growth Rate Analysis of Smith and Nephew plc

    • Figure Revenue and Market Share Analysis of Smith and Nephew plc

    • Table Product and Service Introduction of Smith and Nephew plc

    • Table Company Profile and Development Status of Arthro-Kinetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Arthro-Kinetics

    • Figure Sales and Growth Rate Analysis of Arthro-Kinetics

    • Figure Revenue and Market Share Analysis of Arthro-Kinetics

    • Table Product and Service Introduction of Arthro-Kinetics

    • Table Company Profile and Development Status of Matricel GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Matricel GmbH

    • Figure Sales and Growth Rate Analysis of Matricel GmbH

    • Figure Revenue and Market Share Analysis of Matricel GmbH

    • Table Product and Service Introduction of Matricel GmbH

    • Table Company Profile and Development Status of CartiHeal

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CartiHeal

    • Figure Sales and Growth Rate Analysis of CartiHeal

    • Figure Revenue and Market Share Analysis of CartiHeal

    • Table Product and Service Introduction of CartiHeal

    • Table Company Profile and Development Status of Anika Therapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anika Therapeutics, Inc

    • Figure Sales and Growth Rate Analysis of Anika Therapeutics, Inc

    • Figure Revenue and Market Share Analysis of Anika Therapeutics, Inc

    • Table Product and Service Introduction of Anika Therapeutics, Inc

    • Table Company Profile and Development Status of Zimmer Biomet Holdings

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zimmer Biomet Holdings

    • Figure Sales and Growth Rate Analysis of Zimmer Biomet Holdings

    • Figure Revenue and Market Share Analysis of Zimmer Biomet Holdings

    • Table Product and Service Introduction of Zimmer Biomet Holdings


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US